Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study.

Tytuł:
The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study.
Autorzy:
Graf A; Department of Endocrinology, University College London Hospitals NHS Foundation Trust, London, UK.
Marcus HJ; Division of Neurosurgery, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
Baldeweg SE; Department of Endocrinology, University College London Hospitals NHS Foundation Trust, London, UK. .; Division of Medicine, University College London, London, UK. .
Źródło:
Pituitary [Pituitary] 2021 Apr; Vol. 24 (2), pp. 262-268. Date of Electronic Publication: 2020 Nov 24.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Norwell, MA : Kluwer Academic Publishers, 1998-
MeSH Terms:
Delivery of Health Care*/methods
Delivery of Health Care*/statistics & numerical data
Pandemics*
COVID-19/*epidemiology
Pituitary Diseases/*therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Communicable Disease Control/methods ; Continuity of Patient Care/statistics & numerical data ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Physical Distancing ; Pituitary Diseases/epidemiology ; Quarantine ; SARS-CoV-2/physiology ; Surveys and Questionnaires ; Time-to-Treatment/statistics & numerical data ; United Kingdom/epidemiology ; Young Adult
References:
Fleseriu M, Buchfelder M, Cetas JS et al (2020) Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective. Pituitary 23:327–337. https://doi.org/10.1007/s11102-020-01059-7. (PMID: 10.1007/s11102-020-01059-732556793)
Puig-Domingo M, Marazuela M, Giustina A (2020) COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. European Endocrine Society. https://www.ese-hormones.org/media/2223/covid-and-endocrine-diseases-ese-statement-final_23032020.pdf . Accessed 1 July 2020.
Stewart PM, Biller BM, Marelli C et al (2016) Exploring inpatient hospitalizations and morbidity in patients with adrenal insufficiency. J Clin Endocrinol 101:4843–4850. https://doi.org/10.1210/jc.2016-2221. (PMID: 10.1210/jc.2016-2221)
Arlt W, Baldeweg SE, Pearce S et al Endocrinology in the time of COVID-19: management of adrenal insufficiency. J Endocrinol 183(1):G25–G32. https://eje.bioscientifica.com/view/journals/eje/183/1/EJE-20-0361.xml.
Government of the United Kingdom (2020) Cases in United Kingdom. https://coronavirus.data.gov.uk/cases . Accessed 25 Oct 2020.
Nakamura M, Tanaka F, Komi R et al (2016) Sustained increase in the incidence of acute decompensated heart failure after the 2011 Japan earthquake and Tsunami. Am J Cardiol 118(9):1374–1379. (PMID: 10.1016/j.amjcard.2016.07.055)
Bailey MA, Glover R, Huang Y (2005) Epidemiologic assessment of the impact of four hurricanes—Florida, 2004. Mortal Wkly Rep 54(28):693–697.
Hurricane Katrina Community Advisory Group, Kessler RC (2007) Hurricane Katrina’s impact on the care of survivors with chronic medical conditions. J Gen Intern Med 22(9):1225–1230. (PMID: 10.1007/s11606-007-0294-1)
Miller A, Arquilla B (2008) Chronic diseases and natural hazards: impact of disasters on diabetic, renal, and cardiac patients. Prehosp Disaster Med 23(2):185–194. (PMID: 10.1017/S1049023X00005835)
National Health Service (2020) Check if you or your child has coronavirus symptoms. National Health Service. https://www.nhs.uk/conditions/coronavirus-covid-19/symptoms/ . Accessed 1 July 2020.
Public Health England (2020) Sero-surveillance of COVID-19. Public Health England. https://www.gov.uk/government/publications/national-covid-19-surveillance-reports/sero-surveillance-of-covid-19 . Accessed 30 July 2020.
National Health Service (2020) Cancelled elective operations data. National Health Service. https://www.england.nhs.uk/statistics/statistical-work-areas/cancelled-elective-operations/cancelled-ops-data/ . Accessed 30 July 2020.
National Health Service (2020) Cancer waiting times. National Health Service. https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/ . Accessed 30 July 2020.
Sud A, Jones ME, Broggio J et al (2020) Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol 31(8):1065–1074. (PMID: 10.1016/j.annonc.2020.05.009)
Brooks S, Webster R, Smith L et al (2020) The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 395:912–920. (PMID: 10.1016/S0140-6736(20)30460-8)
British Medical Association (2020) The impact of COVID-19 on mental health in England; Supporting services to go beyond parity of esteem. British Medical Association. https://www.bma.org.uk/what-we-do/population-health/mental-health/the-impact-of-covid-19-on-mental-health-in-england . Accessed 30 July 2020.
Contributed Indexing:
Keywords: COVID-19; Direct; Impact; Indirect; Pandemic; Pituitary
Entry Date(s):
Date Created: 20201125 Date Completed: 20210325 Latest Revision: 20210325
Update Code:
20240105
PubMed Central ID:
PMC7685296
DOI:
10.1007/s11102-020-01106-3
PMID:
33236181
Czasopismo naukowe
Purpose: The coronavirus disease 2019 (COVID-19) pandemic is widely believed to have had a major impact on the care of patients with pituitary disease. The virus itself may directly result in death, and patients with adrenal insufficiency, often a part of hypopituitarism, are thought to represent a particularly susceptible subgroup. Moreover, even in patients that do not contract the virus, the diversion of resources by healthcare institutions to manage the virus may indirectly result in delays in their management. To this end, the aim of this study was to determine the direct and indirect impact of the COVID-19 pandemic on patients with pituitary disease.
Methods: A cross-sectional study design was adopted, with all adult patients seen by our pituitary service in the year prior to the nationwide lockdown on March 23rd 2020 invited to participate in a telephone survey.
Results: In all, 412 patients (412/586; 70.3%) participated in the survey. 66 patients (66/412; 16.0%) reported having suspected COVID-19 infection. Of the 10 patients in this group tested for COVID-19 infection, three received a positive test result. No deaths due to COVID-19 were identified. 267 patients (267/412; 64.8%) experienced a delay or change in the planned care for their pituitary disease, with 100 patients (100/412; 24.3%) perceiving an impact to their care.
Conclusions: Whilst only a small percentage of patients had confirmed or suspected COVID-19 infection, over half were still indirectly impacted by the pandemic through a delay or change to their planned care.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies